VMCS VisualMED Clinical Solutions Corporation (PK)

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces that a major article in the New York Times analyzes the failure of old IT models and practices in the giant $20 billion dollar British Health IT program that ended in a resounding fiasco. The Times article describes the British program as "...an ambitious drive to computerize England's health records and let doctors, clinics and hospitals share patient information."

"The UK failure was predictable," says Chairman Gerard Dab. "The project was managed by British Telecom, who shunned physician input and paid the price." Implementation was turned over to engineers from major American and Japanese IT service corporations. Attempted input from medical schools and physicians was not welcomed. Imperial College of London was ignored when it recommended doctor-designed medical solutions from VisualMED.

A senior Physician from the University of Manchester, UK, has recently stated that the project has been moribund for years. He says that beyond the delays and mismanagement, there have been almost no successful implementations even of the seemingly simple applications such as e-Prescribing and e-Booking, let alone of EHRs.

The fatal engineering bias is confirmed by Dr. David J. Brailer, former national coordinator for health information technology in the Bush administration, who is quoted in the article as saying that "The experience in Britain is a warning to us. The thing that brought them to their knees was the confrontation with doctors."

Coming on the heels of Google's withdrawal from healthcare, the massive British failure makes it abundantly clear that going forward; institutions must turn to physician-driven solutions like those of VisualMED. These developments have begun to weaken the position of big IT service companies and this will translate into greater market penetration for the handful of physician-driven companies like VisualMED.

This helps explain the sudden progress of VisualMED in the past two years, a positive trend that shows no sign of slowing down as the Company's first quarter indicates. Revenues for the quarter show a marked increase of more than 400% over the same period last year.

"We are very encouraged by the recent turn of events. After years of being ahead of the curve, the market is finally moving in our direction," concludes Gerard Dab.

ABOUT VISUALMED VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results. For further information, please contact:

Frederick Berlin Operations manager TEL: 514 836 1212 or 514 582 5220